Institution
Celal Bayar University
Education•Magnesia ad Sipylum, Turkey•
About: Celal Bayar University is a education organization based out in Magnesia ad Sipylum, Turkey. It is known for research contribution in the topics: Population & Heat transfer. The organization has 2960 authors who have published 6024 publications receiving 100646 citations.
Topics: Population, Heat transfer, Nanofluid, Nonlinear system, Medicine
Papers published on a yearly basis
Papers
More filters
TL;DR: Overall, MAP preserved chemical, microbiological and sensory properties of Turkish pastirma better than AP or VP and should be the preferred choice of packaging in order to preserve overall quality of Turkish Pastirma.
96 citations
McMaster University1, Charité2, Ghent University3, University of Genoa4, Creighton University5, Erasmus University Rotterdam6, Teikyo University7, University of Cape Town8, Imperial College London9, Federal University of Bahia10, Georgia Regents University11, University of South Florida12, National Institutes of Health13, Seconda Università degli Studi di Napoli14, Laval University15, Universidade Federal de Minas Gerais16, University of Oslo17, Leiden University18, University of Porto19, University of Amsterdam20, University of Helsinki21, Hacettepe University22, Medical University of Łódź23, Guangzhou Medical University24, Tishreen University25, University of Barcelona26, University of Chicago27, Monash University28, National and Kapodistrian University of Athens29, Nippon Medical School30, University of Aberdeen31, Medical University of Warsaw32, University of Manitoba33, Celal Bayar University34, Transilvania University of Brașov35, French Institute of Health and Medical Research36, University of Modena and Reggio Emilia37, University of Tennessee Health Science Center38, University of Ghana39, University of Wisconsin-Madison40, University of British Columbia41, University of Montpellier42, University of Manchester43, Aarhus University44, Vilnius University45, University of Washington46, University of Paris-Sud47, University of St Andrews48, Washington University in St. Louis49, Seoul National University50, University of Poitiers51, Université de Montréal52, University of Dundee53, University of Sharjah54, University of Mississippi55, Boston Children's Hospital56, University of California, San Diego57, Federal University of São Paulo58, German Red Cross59, Jagiellonian University60, Chiba University61, American Pharmacists Association62, Sofia Medical University63, University of Nevada, Reno64, Finnish Institute of Occupational Health65, Catholic University of Leuven66, Radboud University Nijmegen67, University of Rostock68, National University of Singapore69, Karolinska Institutet70, University of North Carolina at Chapel Hill71, University of Minnesota72, Catholic University of Cordoba73
TL;DR: Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper.
Abstract: The links between asthma and rhinitis are well characterized. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines stress the importance of these links and provide guidance for their prevention and treatment. Despite effective treatments being available, too few patients receive appropriate medical care for both diseases. Most patients with rhinitis and asthma consult primary care physicians and therefore these physicians are encouraged to understand and use ARIA guidelines. Patients should also be informed about these guidelines to raise their awareness of optimal care and increase control of the two related diseases. To apply these guidelines, clinicians and patients need to understand how and why the recommendations were made. The goal of the ARIA guidelines is to provide recommendations about the best management options for most patients in most situations. These recommendations should be based on the best available evidence. Making recommendations requires the assessment of the quality of available evidence, deciding on the balance between benefits and downsides, consideration of patients’ values and preferences, and, if applicable, resource implications. Guidelines must be updated as new management options become available or important new evidence emerges. Transparent reporting of guidelines facilitates understanding and acceptance, but implementation strategies need to be improved.
96 citations
Pompeu Fabra University1, Université Paris-Saclay2, University of Porto3, University of Coimbra4, University of Salerno5, University of Bari6, Federal University of Bahia7, University of São Paulo8, Universidade Federal de Santa Catarina9, Mexican Social Security Institute10, Vilnius University11, European Union of Medical Specialists12, Medical University of Łódź13, Medical University of Warsaw14, Heidelberg University15, University of Cologne16, University of Paris17, University of Montpellier18, University of Barcelona19, Medical University of Graz20, Leiden University Medical Center21, University of Amsterdam22, University of Edinburgh23, University of Helsinki24, University of Turku25, National and Kapodistrian University of Athens26, University of Manchester27, University of Crete28, Eskişehir Osmangazi University29, Istanbul University30, Celal Bayar University31, Woolcock Institute of Medical Research32, Monash University33, Ghent University Hospital34, Odense University Hospital35, Karolinska Institutet36, Uppsala University37, Transylvania University38, Saint Louis University39, University of South Florida40, Nova Southeastern University41, McMaster University42, French Institute of Health and Medical Research43
TL;DR: This observational study using a very simple assessment tool (VAS) on a mobile phone had the potential to answer questions previously thought infeasible on medication use, disease control, and work productivity in patients with AR.
Abstract: Background: Mobile health can be used to generate innovative insights into optimizing treatment to improve allergic rhinitis (AR) control.Objectives: A cross-sectional real-world observational study was undertaken in 22 countries to complement a pilot study and provide novel information on medication use, disease control, and work productivity in the everyday life of patients with AR.Methods: A mobile phone app (Allergy Diary, which is freely available on Google Play and Apple stores) was used to collect the data of daily visual analogue scale (VAS) scores for (1) overall allergic symptoms; (2) nasal, ocular, and asthma symptoms; (3) work; and (4) medication use by using a treatment scroll list including all allergy medications (prescribed and over-the-counter) customized for 22 countries. The 4 most common intranasal medications containing intranasal corticosteroids and 8 oral H-1-antihistamines were studied.Results: Nine thousand one hundred twenty-two users filled in 112,054 days of VASs in 2016 and 2017. Assessment of days was informative. Control of days with rhinitis differed between no (best control), single (good control for intranasal corticosteroid-treated days), or multiple (worst control) treatments. Users with the worst control increased the range of treatments being used. The same trend was found for asthma, eye symptoms, and work productivity. Differences between oral H-1-antihistamines were found.Conclusions: This study confirms the usefulness of the Allergy Diary in accessing and assessing behavior in patients with AR. This observational study using a very simple assessment tool (VAS) on a mobile phone had the potential to answer questions previously thought infeasible.
96 citations
TL;DR: Motivation and metacognition are important predictors of learning in schizophrenia and Psychological interventions in schizophrenia may consider incorporating techniques to stimulate metacognitive and motivational abilities as well as developing individualized training programs.
96 citations
French Institute of Health and Medical Research1, Humanitas University2, University of Naples Federico II3, University of Salerno4, Nova Southeastern University5, University of Porto6, University of Coimbra7, Pierre-and-Marie-Curie University8, University of Paris9, Medical University of Łódź10, Medical University of Warsaw11, Pompeu Fabra University12, University of Barcelona13, Medical University of Graz14, Charité15, University of Würzburg16, University of Cologne17, University of Aberdeen18, University of Edinburgh19, Leiden University Medical Center20, Academic Medical Center21, Vilnius University22, European Union of Medical Specialists23, Ghent University Hospital24, Katholieke Universiteit Leuven25, Karolinska Institutet26, University of Southern Denmark27, University of Helsinki28, University of Manchester29, National and Kapodistrian University of Athens30, Woolcock Institute of Medical Research31, Federal University of Bahia32, Istanbul University33, Monash University34, University of Grenoble35, Université catholique de Louvain36, Celal Bayar University37
TL;DR: In a pilot study, this work attempted to provide additional and complementary insights on the real‐life treatment of allergic rhinitis (AR) using mobile technology.
Abstract: Large observational implementation studies are needed to triangulate the findings from randomized control trials (RCTs) as they reflect "real world" everyday practice. In a pilot study, we attempted to provide additional and complementary insights on the real life treatment of allergic rhinitis using mobile technology. A mobile phone app (Allergy Diary, freely available Google Play and Apple App stores) collects the data of daily visual analogue scales (VAS) for (i) overall allergic symptoms, (ii) nasal, ocular and asthma symptoms, (iii) work, as well as (iv) medication use using a treatment scroll list including all medications (prescribed and over the counter (OTC)) for rhinitis customized for 15 countries. A total of 2,871 users filled in 17,091 days of VAS in 2015 and 2016. Medications were reported for 9,634 days. The assessment of days appeared to be more informative than the course of the treatment as, in real life, patients do not necessarily use treatment on a daily basis; rather, they appear to increase treatment use with the loss of symptom control. The Allergy Diary allowed differentiation between treatments within or between classes (intranasal corticosteroid use containing medications and oral H1-antihistamines). The control of days differed between no [best control], single or multiple treatments (worst control). The present study confirms the usefulness of the Allergy Diary in accessing and assessing everyday use and practice in allergic rhinitis. This pilot observational study uses a very simple assessment (VAS) on a mobile phone, shows novel findings and generates new hypotheses. This article is protected by copyright. All rights reserved
95 citations
Authors
Showing all 3053 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Michael Berk | 116 | 1284 | 57743 |
| G. Raven | 114 | 1879 | 71839 |
| Tjeerd Ketel | 99 | 1067 | 46335 |
| Francesco Dettori | 95 | 1026 | 41313 |
| Manuel Schiller | 95 | 1004 | 41734 |
| John A. McGrath | 75 | 631 | 24078 |
| E. Pesen | 50 | 206 | 10958 |
| Devendra Singh | 49 | 314 | 10386 |
| Fatih Selimefendigil | 43 | 178 | 4522 |
| Mehmet Karabacak | 40 | 111 | 3515 |
| Nurullah Akkoc | 38 | 193 | 7626 |
| Daiana Stolz | 38 | 239 | 7708 |
| Menemşe Gümüşderelioğlu | 34 | 136 | 3328 |
| Mehmet Sezer | 34 | 184 | 3543 |
| Mehmet Pakdemirli | 33 | 137 | 3581 |